- Presentations
- 2
- Markets
- 1
Saphnelo is a brand of Anifrolumab marketed by AstraZeneca Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Anifrolumab
- Brand owner
- AstraZeneca Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 120 mg/0.8 mL injection, 300 mg/2 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Saphnelo 120 mg/0.8 mL injectionSubcutaneous Cold chain | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Saphnelo 300 mg/2 mL injectionIntravenous Cold chain | AstraZeneca Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Saphnelo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.